NanoVibronix Inc., a medical technology company, has successfully closed a significant public offering of debt securities, specifically Series G Convertible Preferred Stock and Warrants. The offering included 400,000 shares of Preferred Stock, each with a par value of $0.001 and a stated value of $25, coupled with Warrants to purchase up to 4,901,982 shares of common stock at an exercise price of $2.04 per share. The offering generated gross proceeds of approximately $10 million. The funds will be used for redeeming outstanding debentures and notes, as well as for general corporate purposes. Further details and the final prospectus for the offering can be accessed at https://www.sec.gov.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.